201 related articles for article (PubMed ID: 8525050)
1. Blocking CD28/B7 with soluble competitors: immunological phenotype of mCTLA4-H gamma 1 transgenic mice.
Lane P
Res Immunol; 1995; 146(3):176-9. PubMed ID: 8525050
[No Abstract] [Full Text] [Related]
2. CD28/CTLA-4 receptor structure, binding stoichiometry and aggregation during T-cell activation.
Linsley PS; Ledbetter J; Peach R; Bajorath J
Res Immunol; 1995; 146(3):130-40. PubMed ID: 8525042
[No Abstract] [Full Text] [Related]
3. CTLA-4 and T cell activation.
Oosterwegel MA; Greenwald RJ; Mandelbrot DA; Lorsbach RB; Sharpe AH
Curr Opin Immunol; 1999 Jun; 11(3):294-300. PubMed ID: 10375557
[TBL] [Abstract][Full Text] [Related]
4. The complexities of T-cell co-stimulation: CD28 and beyond.
Sperling AI; Bluestone JA
Immunol Rev; 1996 Oct; 153():155-82. PubMed ID: 9010723
[No Abstract] [Full Text] [Related]
5. CD80 (B7-1) and CD86 (B7-2): potential targets for immunotherapy?
van Gool SW; Barcy S; Devos S; Vandenberghe P; Ceuppens JL; Thielemans K; de Boer M
Res Immunol; 1995; 146(3):183-96. PubMed ID: 8525052
[No Abstract] [Full Text] [Related]
6. Treatment of autoimmunity by inhibition of T cell costimulation.
Daikh DI; Wofsy D
Adv Exp Med Biol; 2001; 490():113-7. PubMed ID: 11505969
[No Abstract] [Full Text] [Related]
7. B7-CTLA4 interaction promotes cognate destruction of tumor cells by cytotoxic T lymphocytes in vivo.
Bai XF; Liu J; May KF; Guo Y; Zheng P; Liu Y
Blood; 2002 Apr; 99(8):2880-9. PubMed ID: 11929778
[TBL] [Abstract][Full Text] [Related]
8. The role of B7 costimulation in T-cell immunity.
Harris NL; Ronchese F
Immunol Cell Biol; 1999 Aug; 77(4):304-11. PubMed ID: 10457196
[TBL] [Abstract][Full Text] [Related]
9. Role of B7 signaling in the differentiation of naive CD4+ T cells to effector interleukin-4-producing T helper cells.
Gause WC; Urban JF; Linsley P; Lu P
Immunol Res; 1995; 14(3):176-88. PubMed ID: 8778208
[TBL] [Abstract][Full Text] [Related]
10. New protein steals the show as 'costimulator' of T cells.
Cohen J
Science; 1993 Nov; 262(5135):844-5. PubMed ID: 7694360
[No Abstract] [Full Text] [Related]
11. Cytokines and cancer immunotherapy.
Wolf SF; Lee K; Swiniarski H; O'Toole M; Sturmhoefel K
Immunol Invest; 2000 May; 29(2):143-6. PubMed ID: 10854183
[No Abstract] [Full Text] [Related]
12. The IgV domain of human B7-2 (CD86) is sufficient to co-stimulate T lymphocytes and induce cytokine secretion.
Rennert P; Furlong K; Jellis C; Greenfield E; Freeman GJ; Ueda Y; Levine B; June CH; Gray GS
Int Immunol; 1997 Jun; 9(6):805-13. PubMed ID: 9199963
[TBL] [Abstract][Full Text] [Related]
13. Regulation of T and B cell responses by modulating interactions between CD28/CTLA4 and their ligands, CD80 and CD86.
Lane P
Ann N Y Acad Sci; 1997 Apr; 815():392-400. PubMed ID: 9186685
[TBL] [Abstract][Full Text] [Related]
14. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
Van Gool SW; Vermeiren J; Rafiq K; Lorr K; de Boer M; Ceuppens JL
Eur J Immunol; 1999 Aug; 29(8):2367-75. PubMed ID: 10458748
[TBL] [Abstract][Full Text] [Related]
15. The role of B7 costimulation in CD4/CD8 T cell homeostasis.
Yu X; Fournier S; Allison JP; Sharpe AH; Hodes RJ
J Immunol; 2000 Apr; 164(7):3543-53. PubMed ID: 10725709
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the costimulatory requirements for generating human virus-specific in vitro T helper and effector responses.
Blazevic V; Trubey CM; Shearer GM
J Clin Immunol; 2001 Jul; 21(4):293-302. PubMed ID: 11506200
[TBL] [Abstract][Full Text] [Related]
17. Cattle CTLA-4, CD28 and chicken CD28 bind CD86: MYPPPY is not conserved in cattle CD28.
Parsons KR; Young JR; Collins BA; Howard CJ
Immunogenetics; 1996; 43(6):388-91. PubMed ID: 8606060
[No Abstract] [Full Text] [Related]
18. Induction of CD4 T cell changes in murine AIDS is dependent on costimulation and involves a dysregulation of homeostasis.
Yen MH; Lepak N; Swain SL
J Immunol; 2002 Jul; 169(2):722-31. PubMed ID: 12097374
[TBL] [Abstract][Full Text] [Related]
19. Mice transgenic for a soluble form of murine CTLA-4 show enhanced expansion of antigen-specific CD4+ T cells and defective antibody production in vivo.
Ronchese F; Hausmann B; Hubele S; Lane P
J Exp Med; 1994 Mar; 179(3):809-17. PubMed ID: 8113677
[TBL] [Abstract][Full Text] [Related]
20. Enhanced expression of CTLA-4 (CD152) on CD4+ T cells in HIV infection.
Steiner K; Waase I; Rau T; Dietrich M; Fleischer B; Bröker BM
Clin Exp Immunol; 1999 Mar; 115(3):451-7. PubMed ID: 10193417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]